Transplant-related survival benefit should influence prioritization for liver transplantation especially in patients with hepatocellular carcinoma.

about

Trends in the Mortality of Hepatocellular Carcinoma in the United States.Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.

P2860

Q38635553-2386FC6C-3057-4DF2-9228-0B75EE738111 Q39179820-B54BB5E2-E967-416B-9DB4-3893FE5A0ACA

P2860

Transplant-related survival benefit should influence prioritization for liver transplantation especially in patients with hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q39049983

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Transplant-related survival be ...... with hepatocellular carcinoma.

@en

Transplant-related survival be ...... with hepatocellular carcinoma.

@nl

type

Item

label

Transplant-related survival be ...... with hepatocellular carcinoma.

@en

Transplant-related survival be ...... with hepatocellular carcinoma.

@nl

prefLabel

Transplant-related survival be ...... with hepatocellular carcinoma.

@en

Transplant-related survival be ...... with hepatocellular carcinoma.

@nl

P1476

Transplant-related survival be ...... with hepatocellular carcinoma.

@en

P2093

George N Ioannou

http://www.w3.org/2001/XMLSchema#string

P2860

Toward a better liver graft allocation that accounts for candidates with and without hepatocellular carcinoma

Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.

Survival benefit-based deceased-donor liver allocation

Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.

Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing.

Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria

Are patients with Child's A cirrhosis and hepatocellular carcinoma appropriate candidates for liver transplantation?

Model for end-stage liver disease score and MELD exceptions: 15 years later.

Projected outcomes of 6-month delay in exception points versus an equivalent Model for End-Stage Liver Disease score for hepatocellular carcinoma liver transplant candidates.

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

P304

652-662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LT.24690

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28006870

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

Transplant-related survival benefit should influence prioritization for liver transplantation especially in patients with hepatocellular carcinoma.

about

P2860

P2860

Transplant-related survival benefit should influence prioritization for liver transplantation especially in patients with hepatocellular carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921